May 25, 2025 - 04:07

Renewed calls have emerged for former President Joe Biden's physician and close aides to provide testimony in a congressional investigation focused on his health. This inquiry has gained traction as lawmakers seek to assess the implications of Biden's medical condition on his capacity to perform presidential duties.
The discussion around Biden's health has been a contentious topic, with various factions expressing concerns about transparency and accountability. Proponents of the inquiry argue that understanding the president's health is crucial for national security and governance, especially as he navigates significant political challenges.
Critics, however, caution that such demands may be politically motivated, potentially undermining the integrity of the office. As the debate unfolds, it remains to be seen how the administration will respond to these demands for testimony. This situation highlights the ongoing scrutiny of presidential health and its impact on leadership in the United States.
June 9, 2026 - 09:19
Alcohol’s Health Risks Accelerate After One Drink a Day, Study FindsA major new study has concluded that the health risks associated with alcohol consumption accelerate significantly after a person has just one drink per day. The research, which analyzed data from...
June 8, 2026 - 19:43
Opinion | Why repealing Minneapolis’ bathhouse ban could be a public health winHistory has shown multiple times how invocations of a particular concept of morality can be weaponized against queer people with ramifications on public health and civic good, two professors write....
June 8, 2026 - 04:56
‘Strength doesn’t mean silence’: Men talk mental health at Jacksonville field dayOn the surface, it looked like a day of friendly competition, laughter, and games. But organizers say a Men`s Mental Health Awareness Field Day held in Jacksonville was built around a much deeper...
June 7, 2026 - 10:52
How Investors May Respond To OPKO Health (OPK) Boosting Its Nicoya Stake And RAYALDEE MilestonesOPKO Health has strengthened its hand in the Chinese market by expanding its equity stake in Nicoya Therapeutics, while also locking in a clearer path to milestone payments for its kidney disease...